Level of 8-OHdG in drained dialysate appears to be a marker of peritoneal damage in peritoneal dialysis

International Journal of Nephrology and Renovascular Disease

Volumn 5, Issue , 2012, Pages 9-14

  Morishita, Yoshiyuki ^a   Watanabe, Minami ^a   Hirahara, Ichiro ^a   Akimoto, Tetsu ^a   Muto, Shigeaki ^a   Kusano, Eiji ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

MMP 2; Oxidative stress; Peritoneal equilibration test; Solute transport rate

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; GELATINASE A; GLUCOSE; HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSATE LEVEL; DIALYSATE PLASMA CREATININE RATIO; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; FUNCTION TEST; HUMAN; KIDNEY FUNCTION; MALE; OXIDATIVE STRESS; PERITONEAL DAMAGE; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PERITONEAL EQUILIBRATION TEST; PERITONITIS; SOLUTE TRANSPORT RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84856984089     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Krediet RT. Advances in peritoneal dialysis. Minerva Urol Nefrol. 2007; 59(3):251-260.
2. Burkart J, Piraino B, Kaldas H, et al. Why is the evidence favoring hemodialysis over peritoneal dialysis misleading? Semin Dial. 2007;20(3): 200-202.
3. Van Biesen W, Vanholder R, Lameire N. The role of peritoneal dialysis as the first-line renal replacement modality. Perit Dial Int. 2000;20(4):375-383.
4. Hung KY, Huang JW, Tsai TJ, Chen WY. Natural changes in peritoneal equilibration test results in continuous ambulatory peritoneal dialysis patients: a retrospective, seven year cohort survey. Artif Organs. 2000; 24(4):261-264.
5. Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470-479.
6. Davies SJ, Phillips L, Naish PF, Russell GI. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12(5):1046-1051.
7. Gandhi VC, Humayun HM, Ing TS, et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med. 1980;140(9):1201-1203.
8. Kawanishi H. Encapsulating peritoneal sclerosis. Nephrology (Carlton). 2005;10(3):249-255.
9. Kawaguchi Y, Saito A, Kawanishi H, et al. Recommendations on the management of encapsulating peritoneal sclerosis in Japan, 2005: diagnosis, predictive markers, treatment, and preventive measures. Perit Dial Int. 2005;25 Suppl 4:S83-S95.
10. Twardowski ZJ, Nolph KD, Khanna R. Limitations of the peritoneal equilibration test. Nephrol Dial Transplant. 1995;10(11): 2160-2161.
11. Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int. 2004;66(3):1257-1265.
12. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int. 2004; 65(4):1170-1179.
13. Noh H, Kim JS, Han KH, et al. Oxidative stress during peritoneal dialysis: implications in functional and structural changes in the membrane. Kidney Int. 2006;69(11):2022-2028.
14. Kihm LP, Müller-Krebs S, Klein J, et al. Benfotiamine protects against peritoneal and kidney damage in peritoneal dialysis. J Am Soc Nephrol. 2011;22(5):914-926.
15. Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis: a multicentre study in Japan. Nephrol Dial Transplant. 2007;22(2):560-567.
16. Hirahara I, Inoue M, Umino T, Saito O, Muto S, Kusano E. Matrix metalloproteinase levels in the drained dialysate reflect the peritoneal solute transport rate: a multicentre study in Japan. Nephrol Dial Transplant. 2011;26(5):1695-1701.
17. Tarng DC, Huang TP, Wei YH, et al. 8-hydroxy-2′-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis. 2000;36(5):934-944.
18. Austin EW, Parrish JM, Kinder DH, Bull RJ. Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. Fundam Appl Toxicol. 1996;31(1):77-82.
19. Gotloib L, Wajsbrot V, Cuperman Y, Shostak A. Acute oxidative stress induces peritoneal hyperpermeability, mesothelial loss, and fibrosis. J Lab Clin Med. 2004;143(1):31-40.
20. Rodrigues AS, Almeida M, Fonseca I, et al. Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation. Nephrol Dial Transplant. 2006; 21(3):763-769.
21. Rodrigues AS, Martins M, Korevaar JC, et al. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters. Am J Nephrol. 2007;27(1):84-91.
22. Van Esch S, Zweers MM, Jansen MA, de Waart DR, van Manen JG, Krediet RT. Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int. 2004; 24(6):554-561.